Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127056831 | 12705683 | 1 | I | 201602 | 20160418 | 20160901 | 20160901 | PER | US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022670 | GLENMARK | 0.00 | Y | 0.00000 | 20160901 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127056831 | 12705683 | 1 | PS | NORETHINDRONE ACETATE. | NORETHINDRONE ACETATE | 1 | Oral | 5 MG, ONE HALF TABLET EVERY DAY | Y | 063120201 | 91090 | TABLET | |||||||
| 127056831 | 12705683 | 2 | SS | PREMARIN | ESTROGENS, CONJUGATED | 1 | Oral | 0.625 MG, OD | U | 0 | .625 | MG | QD | ||||||
| 127056831 | 12705683 | 3 | SS | PREMARIN | ESTROGENS, CONJUGATED | 1 | U | 0 | |||||||||||
| 127056831 | 12705683 | 4 | C | VERAPAMIL | VERAPAMIL HYDROCHLORIDE | 1 | Oral | 240 MG, BID | 0 | 240 | MG | TABLET | BID | ||||||
| 127056831 | 12705683 | 5 | C | VERAPAMIL | VERAPAMIL HYDROCHLORIDE | 1 | 0 | TABLET | |||||||||||
| 127056831 | 12705683 | 6 | C | VERAPAMIL | VERAPAMIL HYDROCHLORIDE | 1 | 0 | TABLET | |||||||||||
| 127056831 | 12705683 | 7 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 10 MG, OD | 0 | 10 | MG | TABLET | QD | ||||||
| 127056831 | 12705683 | 8 | C | PROGESTERONE. | PROGESTERONE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127056831 | 12705683 | 1 | Product used for unknown indication |
| 127056831 | 12705683 | 2 | Menopause |
| 127056831 | 12705683 | 3 | Hormone replacement therapy |
| 127056831 | 12705683 | 4 | Blood pressure measurement |
| 127056831 | 12705683 | 5 | Cluster headache |
| 127056831 | 12705683 | 6 | Hypertension |
| 127056831 | 12705683 | 7 | Hypertension |
| 127056831 | 12705683 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127056831 | 12705683 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127056831 | 12705683 | Chest discomfort | |
| 127056831 | 12705683 | Deep vein thrombosis | |
| 127056831 | 12705683 | Feeling hot | |
| 127056831 | 12705683 | Intentional product use issue | |
| 127056831 | 12705683 | Palpitations | |
| 127056831 | 12705683 | Peripheral swelling | |
| 127056831 | 12705683 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127056831 | 12705683 | 1 | 201604 | 0 | ||
| 127056831 | 12705683 | 4 | 2008 | 0 | ||
| 127056831 | 12705683 | 7 | 2010 | 0 |